151. Least hemolytic, 12.6 kDa, plasmin-like fibrinolytic protease from marine Penicillium steckii KU1.
- Author
-
Kunhiraman S, Haridas M, Basheer SM, Chellappan S, and Abdulhameed S
- Subjects
- Hydrogen-Ion Concentration, Molecular Weight, Kinetics, Fibrinolytic Agents pharmacology, Fibrinolytic Agents chemistry, Fibrinolytic Agents isolation & purification, Temperature, Aquatic Organisms, Animals, Substrate Specificity, Penicillium enzymology, Fibrinolysin metabolism, Fibrinolysin chemistry, Hemolysis drug effects
- Abstract
A novel fibrinolytic enzyme, from the marine fungus Penicillium steckii KU1, was purified to electrophoretic homogeneity. The fibrinolytic protease was purified to 13.56 times with a specific activity of 57.64 U/mg and final yield of 13.93 %. It was found to be a monomeric protein of 12.6 kDa, having optimum activity at 30 °C and pH 8.0. It is a plasmin-like enzyme, showing resemblance to ATP-dependent zinc metalloprotease with isoelectric point (pI) 8.0. Its activity is enhanced by Zn
2+ , and inhibited by ethylenediaminetetraacetic acid (EDTA), Co2+ and Fe2+ . The enzyme interaction with substrate azocasein was endothermic and with inhibitor EDTA exothermic. The Km , Vmax , Kcat and catalytic efficiency of the enzyme for azocasein were determined to be 142.71 μg mL-1 , 285.71 μg min-1 mL-1 , 6.35 S-1 and 4.45 × 10-2 S-1 μg-1 mL respectively. It hydrolyzed all three chains of fibrinogen within 9 h, and dissolved fibrin completely within 24 h. 2 mg/mL enzyme could dissolve blood clot completely within 30 min, with negligible hemolysis (2.60 %). Lowering the immunogenicity by the application of natural or engineered small proteins is a strategy to enhance the safety and efficacy of thrombolytic therapy. Hence, the present 12.6 kDa, plasmin-like fibrinolytic enzyme appears worthy of further investigations towards a thrombolytic therapeutic., Competing Interests: Declaration of competing interest The authors have no relevant financial or non-financial interests to disclose., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF